22. Nov 2021 |
6 min read
Gentian Diagnostics looks forward to exhibit at IFCC EuroMedLab 2021 promoting our turbidimetric cystatin C immunoassay. Visit us at booth #201 to learn more.
More than 4000 journal articles have been published on the clinical relevance of cystatin C since it was discovered as a marker of GFR in 1979 by Dr. Anders Grubb. The rising cost pressures faced by health systems has pushed cystatin C into the forefront of biomarkers that could reduce healthcare costs.
26 years after the first automated assay for cystatin C was developed, Gentian emphasises the unique prognostic and diagnostic value of cystatin C as a marker that:
Visit us during opening hours or book a meeting in advance through firstname.lastname@example.org.
Nov 30, 2021
Biomarker for early detection of the inflammatory response to infections Calprotectin is one of the earliest..
Nov 29, 2021
Recommending increased use of cystatin C Cystatin C is less susceptible to factors that affect muscle mass..
Nov 22, 2021
Meet us at EuroMedLab - Booth #201 Gentian Diagnostics looks forward to exhibit at IFCC EuroMedLab..